Treatment of Neuropsychiatric Symptoms in Alzheimer's Disease with a Cannabis-Based Magistral Formulation: An Open-Label Prospective Cohort Study

• Published in: Medical cannabis and cannabinoids Vol. 7; no. 1; pp. 160 - 170
• Main Authors: Navarro, Cristian E, Pérez, Juan C
• Format: Journal Article
• Language: English
• Published: Switzerland S. Karger AG 12.09.2024; Karger Publishers
• Subjects: alzheimer disease; behavioral symptoms; cannabidiol; cannabis; dementia; Preclinical Science and Clinical Studies; Behavioral symptoms; Cannabidiol; Cannabis; Alzheimer disease; Dementia

Neuropsychiatric symptoms (NPS) may be disruptive and problematic for patients with Alzheimer's disease (AD) and for their caregivers. Cannabidiol (CBD) may be a safer alternative. The objective was to evaluate whether CBD-rich oil was effective, and safe in adults with NPS secondary to AD. An...